Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Alphatec Holdings Inc (ATEC) Insider Trading Activity

    Healthcare • Medical Devices • 839 employees

    Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

    Total Value

    -$4,050,050.42

    Total Shares

    2,021,072

    Average Trade Value

    -$106,580.27

    Most Active Insider

    Miles Patrick

    Total Activity: $2,728,134

    Largest Single Transaction

    $624,211

    by Sponsel David on Jan 13, 2025

    30-Day Activity

    24 Transactions

    Volume: 1,917,002 shares
    Value: $2,451,613

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Chief Operating Officer
    Feb 6, 2025 27,453 $315,435 867,677 (-3.2%) Sale
    CEO
    Feb 5, 2025 43,459 $519,335 6,065,772 (-0.7%) Sale
    Evp, Sales
    Feb 3, 2025 36,256 $414,044 735,074 (-4.9%) Sale
    CEO
    Jan 30, 2025 43,313 $521,055 6,109,231 (-0.7%) Sale
    Evp, People Culture
    Jan 29, 2025 173,417 $0 1,606,558 (+10.8%) Grant
    Chief Operating Officer
    Jan 29, 2025 19,900 $0 895,130 (+2.2%) Grant
    Evp, Sales
    Jan 29, 2025 114,322 $0 750,224 (+15.2%) Grant
    CEO
    Jan 29, 2025 311,634 $0 5,813,349 (+5.4%) Grant
    Chief Financial Officer
    Jan 29, 2025 120,952 $0 514,308 (+23.5%) Grant
    Evp, Sales
    Jan 29, 2025 133,591 $0 635,902 (+21.0%) Grant
    Chief Financial Officer
    Jan 29, 2025 114,322 $0 628,630 (+18.2%) Grant
    Evp, People Culture
    Jan 29, 2025 156,935 $0 1,433,141 (+11.0%) Grant
    CEO
    Jan 29, 2025 48,240 $0 6,202,544 (+0.8%) Grant
    Evp, People Culture
    Jan 29, 2025 21,709 $0 1,628,267 (+1.3%) Grant
    CEO
    Jan 29, 2025 340,955 $0 6,154,304 (+5.5%) Grant
    CEO
    Jan 29, 2025 50,000 $601,500 6,152,544 (-0.8%) Sale
    Chief Operating Officer
    Jan 29, 2025 120,952 $0 701,813 (+17.2%) Grant
    Chief Operating Officer
    Jan 29, 2025 173,417 $0 875,230 (+19.8%) Grant
    General Counsel Corp. Sec.
    Jan 29, 2025 12,965 $0 478,758 (+2.7%) Grant
    General Counsel Corp. Sec.
    Jan 29, 2025 105,833 $0 351,471 (+30.1%) Grant
    General Counsel Corp. Sec.
    Jan 29, 2025 114,322 $0 465,793 (+24.5%) Grant
    Chief Financial Officer
    Jan 29, 2025 19,598 $0 648,228 (+3.0%) Grant
    Evp, Sales
    Jan 29, 2025 21,106 $0 771,330 (+2.7%) Grant
    CEO
    Jan 21, 2025 6,687 $80,244 5,501,715 (-0.1%) Sale
    Evp, Sales
    Jan 13, 2025 58,283 $624,211 502,311 (-11.6%) Sale
    Evp, Sales
    Jan 10, 2025 238 $2,380 560,594 (-0.0%) Sale
    Dec 18, 2024 126,051 $0 414,492 (+30.4%) Grant
    Evp, Sales
    Dec 11, 2024 62,018 $600,954 560,832 (-11.1%) Sale
    Evp, People Culture
    Dec 10, 2024 23,157 $223,465 1,276,206 (-1.8%) Payment of Exercise Price
    Evp, People Culture
    Dec 10, 2024 36,301 $97,650 1,224,745 (+3.0%) Exercise/Conversion
    Evp, People Culture
    Dec 10, 2024 1,866 $3,601 1,226,611 (+0.2%) Exercise/Conversion
    Evp, People Culture
    Dec 10, 2024 72,752 $122,223 1,299,363 (+5.6%) Exercise/Conversion
    CEO
    Nov 21, 2024 50,000 $504,500 5,508,402 (-0.9%) Sale
    CEO
    Nov 20, 2024 50,000 $501,500 5,558,402 (-0.9%) Sale
    Aug 23, 2024 35,000 $201,600 50,000 (+70.0%) Purchase
    Aug 23, 2024 16,978 $100,000 331,696 (+5.1%) Purchase
    Aug 22, 2024 8,818 $49,998 314,718 (+2.8%) Purchase
    Aug 21, 2024 50,000 $283,500 288,441 (+17.3%) Purchase